INS and atherosclerosis: Sodium-glucose co-transport 2 inhibitors exert anti-atherosclerotic properties attenuating inflammatory factors, alleviating inflammation, mitigating insulin resistance, and reducing stress on vessels, inhibiting atherosclerosis development and progression (46).